关注
Pilar García Broncano
Pilar García Broncano
Postdoctoral Research Fellow at Ragon Institute of MGH, MIT and Harvard
在 mgh.harvard.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Loss of Bcl-6-expressing T follicular helper cells and germinal centers in COVID-19
N Kaneko, HH Kuo, J Boucau, JR Farmer, H Allard-Chamard, ...
Cell 183 (1), 143-157. e13, 2020
7142020
Early antiretroviral therapy in neonates with HIV-1 infection restricts viral reservoir size and induces a distinct innate immune profile
P Garcia-Broncano, S Maddali, KB Einkauf, C Jiang, C Gao, J Chevalier, ...
Science translational medicine 11 (520), eaax7350, 2019
1002019
Allelic variation in class I HLA determines CD8+ T cell repertoire shape and cross-reactive memory responses to SARS-CoV-2
JM Francis, D Leistritz-Edwards, A Dunn, C Tarr, J Lehman, C Dempsey, ...
Science immunology 7 (67), eabk3070, 2021
802021
Antiretroviral therapy reduces T-cell activation and immune exhaustion markers in human immunodeficiency virus controllers
JZ Li, FP Segal, RJ Bosch, CM Lalama, C Roberts-Toler, H Delagreverie, ...
Clinical Infectious Diseases 70 (8), 1636-1642, 2020
482020
Dendronized anionic gold nanoparticles: synthesis, characterization, and antiviral activity
CE Peña‐González, P García‐Broncano, MF Ottaviani, M Cangiotti, ...
Chemistry–A European Journal 22 (9), 2987-2999, 2016
482016
Prevention of vaginal and rectal herpes simplex virus type 2 transmission in mice: mechanism of antiviral action
R Cena-Diez, E Vacas-Cordoba, P Garcia-Broncano, FJ de la Mata, ...
International journal of nanomedicine, 2147-2162, 2016
472016
Elevated liver stiffness is linked to increased biomarkers of inflammation and immune activation in HIV/hepatitis C virus-coinfected patients
LM Medrano, P Garcia-Broncano, J Berenguer, J González-García, ...
Aids 32 (9), 1095-1105, 2018
432018
Efficacy of HIV antiviral polyanionic carbosilane dendrimer G2-S16 in the presence of semen
R Cena-Diez, P Garcia-Broncano, FJ de la Mata, R Gomez, ...
International journal of nanomedicine, 2443-2450, 2016
382016
G2-S16 dendrimer as a candidate for a microbicide to prevent HIV-1 infection in women
R Ceña-Diez, P García-Broncano, FJ de la Mata, R Gomez, S Resino, ...
Nanoscale 9 (27), 9732-9742, 2017
322017
Pegylated Interferon-α–Induced Natural Killer Cell Activation Is Associated With Human Immunodeficiency Virus-1 DNA Decline in Antiretroviral Therapy–Treated HIV-1/Hepatitis C …
S Hua, S Vigano, S Tse, O Zhengyu, S Harrington, J Negron, ...
Clinical Infectious Diseases 66 (12), 1910-1917, 2018
292018
Efficacy of carbosilane dendrimers with an antiretroviral combination against HIV-1 in the presence of semen-derived enhancer of viral infection
P Garcia-Broncano, R Cena-Diez, FJ de la Mata, R Gómez, S Resino, ...
European Journal of Pharmacology 811, 155-163, 2017
242017
Immune correlates of HIV-1 reservoir cell decline in early-treated infants
CA Hartana, P Garcia-Broncano, Y Rassadkina, X Lian, C Jiang, ...
Cell Reports 40 (3), 2022
202022
Association between IL7R polymorphisms and severe liver disease in HIV/HCV coinfected patients: a cross-sectional study
M Guzman-Fulgencio, J Berenguer, MA Jiménez-Sousa, D Pineda-Tenor, ...
Journal of translational medicine 13, 1-9, 2015
182015
IL7RA polymorphisms predict the CD4+ recovery in HIV patients on cART
M Guzmán‐Fulgencio, J Berenguer, MA Jiménez‐Sousa, D Micheloud, ...
European journal of clinical investigation 45 (11), 1192-1199, 2015
182015
FTOrs9939609 polymorphism is associated with metabolic disturbances and response to HCV therapy in HIV/HCV-coinfected patients
D Pineda-Tenor, J Berenguer, MA Jiménez-Sousa, M Garcia-Alvarez, ...
BMC medicine 12, 1-11, 2014
182014
Successful HCV therapy reduces liver disease severity and inflammation biomarkers in HIV/HCV-coinfected patients with advanced cirrhosis: a cohort study
LM Medrano, J Berenguer, S Salgüero, J González-García, C Díez, ...
Frontiers in Medicine 8, 615342, 2021
172021
Dysregulation of the immune system in HIV/HCV-coinfected patients according to liver stiffness status
P Garcia-Broncano, LM Medrano, J Berenguer, J González-García, ...
Cells 7 (11), 196, 2018
172018
Viral reservoir in early-treated human immunodeficiency virus-infected children and markers for sustained viral suppression
G Ajibola, P Garcia-Broncano, K Maswabi, K Bennett, MD Hughes, ...
Clinical Infectious Diseases 73 (4), e997-e1003, 2021
162021
Association of adiponectin (ADIPOQ) rs2241766 polymorphism and dyslipidemia in HIV/HCV‐coinfected patients
D Pineda‐Tenor, J Berenguer, P García‐Broncano, MA Jiménez‐Sousa, ...
European journal of clinical investigation 44 (5), 453-462, 2014
162014
Mild profile improvement of immune biomarkers in HIV/HCV-coinfected patients who removed hepatitis C after HCV treatment: A prospective study
P Garcia-Broncano, LM Medrano, J Berenguer, O Brochado-Kith, ...
Journal of Infection 80 (1), 99-110, 2020
142020
系统目前无法执行此操作,请稍后再试。
文章 1–20